Aristotle Atlantic Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$13.2M |
| 2 |
Datadog
DDOG
|
+$9.95M |
| 3 |
Meta Platforms (Facebook)
META
|
+$9.19M |
| 4 |
Applied Materials
AMAT
|
+$6.25M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$5.24M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$25.1M |
| 2 |
Accenture
ACN
|
+$13.7M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$12.3M |
| 4 |
NVIDIA
NVDA
|
+$11.6M |
| 5 |
Microsoft
MSFT
|
+$9.54M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.71% |
| 2 | Healthcare | 14.29% |
| 3 | Consumer Discretionary | 11.02% |
| 4 | Communication Services | 10.15% |
| 5 | Financials | 10.01% |
Similar funds
Aristotle Atlantic Partners's Q1 2024 Portfolio in Review
As of Q1 2024, Aristotle Atlantic Partners held 96 positions worth $3.06B, up 7.8% from $2.84B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Aristotle Atlantic Partners withdrew a net $103M in Q1 2024, closing 4 positions and reducing 58 holdings. Its most notable exit was Northrop Grumman, an estimated $880K position sold in full.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 35% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Aristotle Atlantic Partners added an estimated $13.2M to Vertex Pharmaceuticals.
- Aristotle Atlantic Partners added most to Vertex Pharmaceuticals in Q1 2024, an estimated $13.2M increase.
- Aristotle Atlantic Partners's biggest Q1 2024 reduction was Apple, cutting an estimated $25.1M.
- Aristotle Atlantic Partners fully exited Northrop Grumman in Q1 2024, selling an estimated $880K.
- Aristotle Atlantic Partners's ten largest holdings make up 46% of its $3.06B portfolio in Q1 2024.
- Aristotle Atlantic Partners opened 0 new positions and closed 4 in Q1 2024.
- Aristotle Atlantic Partners's portfolio value rose 7.8% quarter-over-quarter to $3.06B.
Based on Aristotle Atlantic Partners's 13F filing for Q1 2024, filed 15 May 2024.